Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

ClinicalTrials.gov ID: NCT00256932

Public ClinicalTrials.gov record NCT00256932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain

Study identification

NCT ID
NCT00256932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry
Enrollment
518 participants

Conditions and interventions

Interventions

  • alvimopan Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2005
Primary completion
Not listed
Completion
Apr 30, 2006
Last update posted
Sep 1, 2015

2005 – 2006

United States locations

U.S. sites
137
U.S. states
32
U.S. cities
117
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35243
GSK Investigational Site Birmingham Alabama 35244
GSK Investigational Site Calera Alabama 35040
GSK Investigational Site Muscle Shoals Alabama 35662
GSK Investigational Site Tallassee Alabama 36078
GSK Investigational Site Glendale Arizona 85306
GSK Investigational Site Phoenix Arizona 85023
GSK Investigational Site Phoenix Arizona 85032
GSK Investigational Site Sun City Arizona 85351
GSK Investigational Site Tucson Arizona 85711
GSK Investigational Site Tucson Arizona 85741
GSK Investigational Site Hot Springs Arkansas 71913
GSK Investigational Site Little Rock Arkansas 72223
GSK Investigational Site Anaheim California 92801
GSK Investigational Site Anaheim California 92805
GSK Investigational Site Beuna Park California 90620
GSK Investigational Site Burbank California 91505
GSK Investigational Site Duarte California 91010
GSK Investigational Site Fountain Valley California 92708
GSK Investigational Site Huntington Beach California 92648
GSK Investigational Site Mission Viejo California 92691
GSK Investigational Site Orange California 92869
GSK Investigational Site Redlands California 92374
GSK Investigational Site San Diego California 92103-6204
GSK Investigational Site San Diego California 92120
GSK Investigational Site San Diego California 92121
GSK Investigational Site Vista California 92083
GSK Investigational Site Waterbury Connecticut 067708
GSK Investigational Site Newark Delaware 19713
GSK Investigational Site Brandon Florida 33511
GSK Investigational Site Brooksville Florida 34613
GSK Investigational Site DeLand Florida 32720
GSK Investigational Site Fort Meyers Florida 33907
GSK Investigational Site Gainsville Florida 32607
GSK Investigational Site Hollywood Florida 33021
GSK Investigational Site Jacksonville Florida 32256
GSK Investigational Site Jacksonville Florida 32257
GSK Investigational Site Jupiter Florida 33458
GSK Investigational Site Largo Florida 33773
GSK Investigational Site Melbourne Florida 32901
GSK Investigational Site Miami Florida 33145
GSK Investigational Site Miami Florida 33186
GSK Investigational Site Niceville Florida 32578
GSK Investigational Site North Miami Florida 33161
GSK Investigational Site Ocala Florida 32607
GSK Investigational Site Orlando Florida 32804
GSK Investigational Site Ormond Beach Florida 32174
GSK Investigational Site Sarasota Florida 34239
GSK Investigational Site St. Petersburg Florida 33703
GSK Investigational Site Tampa Florida 33603
GSK Investigational Site West Palm Beach Florida 33409
GSK Investigational Site Winter Park Florida 32789
GSK Investigational Site Atlanta Georgia 30308
GSK Investigational Site Dawsonville Georgia 30534
GSK Investigational Site Decatur Georgia 30033
GSK Investigational Site Decatur Georgia 30034
GSK Investigational Site Marietta Georgia 30066
GSK Investigational Site Bloomington Illinois 61701
GSK Investigational Site Rockford Illinois 61107
GSK Investigational Site Elkhart Indiana 46515
GSK Investigational Site Evansville Indiana 47714
GSK Investigational Site Indianapolis Indiana 46202
GSK Investigational Site Indianapolis Indiana 46250
GSK Investigational Site Newburgh Indiana 47630
GSK Investigational Site Lexington Kentucky 40504
GSK Investigational Site Louisville Kentucky 40213
GSK Investigational Site Shreveport Louisiana 71103
GSK Investigational Site Baltimore Maryland 21229-5299
GSK Investigational Site Elkridge Maryland 21075
GSK Investigational Site Boston Massachusetts 02215
GSK Investigational Site Detroit Michigan 48202
GSK Investigational Site Portage Michigan 49024
GSK Investigational Site Saginaw Michigan 48602
GSK Investigational Site Chaska Minnesota 55318
GSK Investigational Site Picayune Mississippi 39466
GSK Investigational Site Fenton Missouri 63026
GSK Investigational Site Manchester Missouri 63021
GSK Investigational Site St Louis Missouri 63128
GSK Investigational Site St Louis Missouri 63141
GSK Investigational Site Omaha Nebraska 68114
GSK Investigational Site Incline Village Nevada 89452
GSK Investigational Site Las Vegas Nevada 89119
GSK Investigational Site Las Vegas Nevada 89146
GSK Investigational Site Elizabeth New Jersey 07202
GSK Investigational Site Haddon Heights New Jersey 08035
GSK Investigational Site Princeton New Jersey 08540
GSK Investigational Site East Syracuse New York 13057
GSK Investigational Site New York New York 10010
GSK Investigational Site New York New York 10016
GSK Investigational Site Valley Stream New York 11580
GSK Investigational Site Charlotte North Carolina 28204
GSK Investigational Site Charlotte North Carolina 28210
GSK Investigational Site Concord North Carolina 28025
GSK Investigational Site Greensboro North Carolina 27401
GSK Investigational Site Salisbury North Carolina 28144
GSK Investigational Site Wilmington North Carolina 28412
GSK Investigational Site Winston-Salem North Carolina 27103
GSK Investigational Site Cincinnati Ohio 45219
GSK Investigational Site Cincinnati Ohio 45224
GSK Investigational Site Columbus Ohio 43215
GSK Investigational Site Dayton Ohio 45408
GSK Investigational Site Dayton Ohio 45439
GSK Investigational Site Maumee Ohio 43537
GSK Investigational Site Oklahoma City Oklahoma 73112
GSK Investigational Site Eugene Oregon 97404
GSK Investigational Site Medford Oregon 97504
GSK Investigational Site Oregon City Oregon 97045
GSK Investigational Site Portland Oregon 97210
GSK Investigational Site Portland Oregon 97225
GSK Investigational Site Portland Oregon 97232
GSK Investigational Site Bala-Cynwyd Pennsylvania 19004
GSK Investigational Site Nazareth Pennsylvania 18064
GSK Investigational Site Whitehall Pennsylvania 18052
GSK Investigational Site Wyomissing Pennsylvania 19610
GSK Investigational Site Warwick Rhode Island 02886
GSK Investigational Site Woonsocket Rhode Island 02895
GSK Investigational Site Charleston South Carolina 29406
GSK Investigational Site Murrells Inlet South Carolina 29576
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Arlington Texas 76017
GSK Investigational Site Brownwood Texas 76801
GSK Investigational Site Colleyville Texas 76034
GSK Investigational Site Galveston Texas 77555
GSK Investigational Site Houston Texas 77054
GSK Investigational Site Houston Texas 77074
GSK Investigational Site Lake Jackson Texas 77566
GSK Investigational Site San Antonio Texas 78205
GSK Investigational Site San Antonio Texas 78238
GSK Investigational Site Alexandria Virginia 22304
GSK Investigational Site Chesapeake Virginia 23322
GSK Investigational Site Christiansburg Virginia 24073
GSK Investigational Site Danville Virginia 24541
GSK Investigational Site Virginia Beach Virginia 23452
GSK Investigational Site Bellingham Washington 98226
GSK Investigational Site Edmonds Washington 98026
GSK Investigational Site Lacey Washington 98516
GSK Investigational Site Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00256932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00256932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →